Sergio Raposeiras-Roubin

19PUBLICATIONS
179CO-AUTHORS
Respiratory diseasesCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Occupational epidemiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 16, 2026
Dapagliflozin After Transcatheter Aortic Valve Implantation According to Frailty in DapaTAVI Trial.

|Aug 27, 2026
Treatment effects of dapagliflozin in patients with aortic stenosis undergoing transcatheter aortic valve implantation across left ventricular ejection fraction.

|Nov 07, 2025
Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial.

Sergio Raposeiras-Roubín, Emad Abu Assi, César Jiménez Méndez

|Sep 15, 2025
Effectiveness and Safety of Lumbar Erector Spinae Plane Block Versus No Locoregional Block in Hip Surgery: Protocol for a Randomized Controlled Trial.

Laura García-Reza, Sergio Raposeiras, Javier P Loureiro

|Dec 23, 2024
Prostatic amyloidosis: pathological features of an underdiagnosed condition.

José A Ortiz-Rey, Jorge Sánchez-Ramos, Samer Abdulkader-Sande

|Oct 27, 2024
Derivation and Validation of the PRECISE-HBR Score to Predict Bleeding After Percutaneous Coronary Intervention.

Felice Gragnano, David van Klaveren, Dik Heg

Pageof 4

Frequent Collaborators

5 joint publications

Aitor Uribarri

4 joint publications

Ivan Javier Nuñez-Gil

3 joint publications

Gabriela Tirado-Conte

3 joint publications

Bernardo Cortese